Narayana Health introduces healthcare insurance, 'Aditi'. It is an INR 10,000 annual premium health insurance covering surgery up to INR 1 crore and treatments at INR 5 lakh. Their main challenges include hospital-centric care and potential overuse of surgeries. They are aiming to complement existing government schemes like Ayushmaan Bharat.
Read moreSun Pharmaceuticals Limited received a USFDA warning letter for its Dadra facility. This was due to cGMP violations following an inspection in December 2023. Despite all the violations and issues Sun Pharma has implemented corrective measures. USFDA will release the letter's contents soon.
Read moreHowever, earlier this week, the company encountered regulatory challenges when its injectable manufacturing site in Jarod, near Vadodara, Gujarat, received 10 observations from the US health regulator post-inspection
Read moreInspection of Dadra Facility by USFDA was initiated on 4th December 2023 and concluded on 15th December 2023. Following the news, Sun Pharma’s shares went down by 3% on the BSE
Read moreWhile Aurobindo Pharma reassured stakeholders about its commitment towards compliance with the US FDA norms, the comments indicate areas that need attention to ensure adherence to the regulatory standards
Read moreHiLabs journey started from Yale University in USA, with a modest team comprising interns and 2 full-time employees based in India, the startup has grown significantly
Read more